nanomedicine

Imagine shrinking a delivery van down until it is thousands of times smaller than a single cell, then loading it with medicine and sending it through the bloodstream. Nanomedicine is the branch of pharmaceutics that designs and uses carriers and materials roughly 1 to 1000 nanometres across to transport, protect and release drugs in the body. At that scale, materials behave differently from bulk powders, and that difference is the whole point.

The aim is to solve problems that ordinary tablets and injections cannot. A poorly water-soluble drug can be carried in a tiny carrier so it dissolves and absorbs better; a fragile molecule like a nucleic acid can be wrapped so enzymes do not destroy it; and a toxic drug can be steered toward diseased tissue so that less of it reaches healthy organs. Familiar examples include liposomal doxorubicin for cancer and the lipid nanoparticles that carry mRNA vaccines.

Nanomedicine is genuinely useful but not magic. Manufacturing nanoscale carriers reproducibly at large scale is hard, the body's immune system and liver clear many of them quickly, and a carrier that works beautifully in a mouse often disappoints in patients. It is one tool among many, best chosen when a conventional dosage form simply cannot do the job.